Despite these limitations, we believe that this study provides clinicians with useful information to approach their GBA1-PD patients in the clinic, tailoring their counselling on prognosis and disease trajectories, and integrating our recent consensus guidance on PD risk1. The gene discussed is GBA1; the disease is Parkinson disease.